Walleye Capital’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,534
| Closed | -$502K | – | 2806 |
|
|
2024
Q1 | $502K | Buy |
15,534
+10,639
| +217% | +$344K | ﹤0.01% | 1382 |
|
|
2023
Q4 | $206K | Sell |
4,895
-25,567
| -84% | -$1.08M | ﹤0.01% | 1478 |
|
|
2023
Q3 | $1.17M | Buy |
+30,462
| New | +$1.17M | ﹤0.01% | 838 |
|
|
2023
Q1 | – | Sell |
-533,840
| Closed | -$9.48M | – | 2423 |
|
|
2022
Q4 | $9.48M | Buy |
533,840
+366,270
| +219% | +$6.5M | 0.17% | 128 |
|
|
2022
Q3 | $935K | Buy |
+167,570
| New | +$935K | 0.02% | 756 |
|
|
2022
Q1 | – | Sell |
-32,956
| Closed | -$281K | – | 2348 |
|
|
2021
Q4 | $281K | Buy |
32,956
+17,121
| +108% | +$146K | 0.01% | 1254 |
|
|
2021
Q3 | $138 | Sell |
15,835
-19,310
| -55% | -$168 | ﹤0.01% | 1235 |
|
|
2021
Q2 | $371 | Sell |
35,145
-4,741
| -12% | -$50 | 0.01% | 845 |
|
|
2021
Q1 | $640 | Buy |
+39,886
| New | +$640 | 0.04% | 465 |
|